Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 4
Submit an article Journal homepage
898
Views
18
CrossRef citations to date
0
Altmetric
Author's View

The controversial role of TNF in melanoma

Marco DoniaCenter for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark;Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, DenmarkCorrespondence[email protected] [email protected]
,
Julie Westerlin KjeldsenCenter for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark
&
Inge Marie SvaneCenter for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark;Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, DenmarkCorrespondence[email protected] [email protected]
Article: e1107699 | Received 07 Oct 2015, Accepted 08 Oct 2015, Published online: 08 Apr 2016

References

  • Aggarwal BB, Gupta SC, Kim JH. Review article Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Hematology 2012; 119:651-65; PMID:22053109; http://dx.doi.org/10.1182/blood-2011-04-325225
  • Katerinaki E, Evans GS, Lorigan PC, MacNeil S. TNF-alpha increases human melanoma cell invasion and migration in vitro: the role of proteolytic enzymes. Br J Cancer 2003; 89:1123-9. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2376936&tool=pmcentrez&rendertype=abstract; PMID:12966436; http://dx.doi.org/10.1038/sj.bjc.6601257
  • Bald T, Quast T, Landsberg J, Rogava M, Glodde N, Lopez-Ramos D, Kohlmeyer J, Riesenberg S, van den Boorn-Konijnenberg D, Hömig-Hölzel C et al. Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 2014; 507:109-13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24572365; PMID:24572365; http://dx.doi.org/10.1038/nature13111
  • Landsberg J, Kohlmeyer J, Renn M, Bald T, Rogava M, Cron M, Fatho M, Lennerz V, Wölfel T, Hölzel M et al. Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 2012; 490:412-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23051752; PMID:23051752; http://dx.doi.org/10.1038/nature11538
  • Bertrand F, Rochotte J, Colacios C, Montfort A, Tilkin-Mariame A-F, Touriol C, Rochaix P, Lajoie-Mazenc I, Andrieu-Abadie N, Levade et al. Blocking Tumor Necrosis Factor enhances CD8 T cell-dependent immunity in experimental melanoma. Cancer Res 2015; 75(13):2619-28; Available from: http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.CAN-14-2524; PMID: 25977337; http://dx.doi.org/10.1158/0008-5472.CAN-14-2524
  • Waterston AM, Salway F, Andreakos E, Butler DM, Feldmann M, Coombes RC. TNF autovaccination induces selfanti-TNF antibodies and inhibits metastasis in a murine melanoma model. BrJ Cancer 2004; 90:1279-84. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2409655&tool=pmcentrez&rendertype=abstract; PMID:15026813; http://dx.doi.org/10.1038/sj.bjc.6601670
  • Mercer L, Askling J, Raaschou P, Dixon W, Dreyer L, Hetland ML, Mellemkjær L, Strangfeld A, Zink A, Iannone F et al. No Increased Risk of Developing a First Invasive Melanoma in Rheumatoid Arthritis Patients Treated with Biologics: Results of a Collaborative Project of 11 European Biologics Registers. In: American College of Rheumatology Annual Meeting. 2014. page 1838.
  • Donia M, Andersen R, Kjeldsen JW, Fagone P, Munir S, Nicoletti F, Andersen MH, thor Straten P, Svane IM. Aberrant expression of MHC Class II in melanoma attracts inflammatory tumor specific CD4+ T cells which dampen CD8+ T cell antitumor reactivity. Cancer Res 2015; 75(18):3747-59; Available from: http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.CAN-14-2956; PMID:26183926; http://dx.doi.org/10.1158/0008-5472.CAN-14-2956
  • Garrido F, Romero I, Aptsiauri N, Garcia-Lora AM. Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype. Int J Cancer 2014; 2:n/a-n/a. Available from: http://doi.wiley.com/10.1002/ijc.29375; PMID:25471439; http://dx.doi.org/10.1002/ijc.29375
  • Brown ER, Charles KA, Hoare SA, Rye RL, Jodrell DI, Aird RE, Vora R, Prabhakar U, Nakada M, Corringham RE et al. A clinical study assessing the tolerability and biological effects of infliximab, a TNF- inhibitor, in patients with advanced cancer. Ann Oncol 2008; 19:1340-6. Available from: http://annonc.oxfordjournals.org/cgi/doi/10.1093/annonc/mdn054; PMID:18325912; http://dx.doi.org/10.1093/annonc/mdn054

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.